載入...
Consequences of the 340B Drug Pricing Program
BACKGROUND: The 340B Drug Pricing Program entitles qualifying hospitals to discounts on outpatient drugs, increasing the profitability of drug administration. By tying the program eligibility of hospitals to their Disproportionate Share Hospital (DSH) adjustment percentage, which reflects the propor...
Na minha lista:
| 發表在: | N Engl J Med |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6073067/ https://ncbi.nlm.nih.gov/pubmed/29365282 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMsa1706475 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|